These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 34863149

  • 1. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C, Jung J, Wachter A, Ibing S, Will R, Uhlmann S, Mannsperger H, Sahin Ö, Yarden Y, Beißbarth T, Korf U, Körner C, Wiemann S.
    BMC Cancer; 2021 Dec 04; 21(1):1296. PubMed ID: 34863149
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
    Nie J, Jiang HC, Zhou YC, Jiang B, He WJ, Wang YF, Dong J.
    Biosci Biotechnol Biochem; 2019 Jun 04; 83(6):1062-1071. PubMed ID: 30950326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway.
    Zhu S, Sun J, Liu X, Shao H, Feng C, Wang Z, Zheng X, Wei S.
    Mol Cell Biol; 2022 Jun 16; 42(6):e0018821. PubMed ID: 35499320
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S, Hosseini V, Paryan M.
    J Cell Physiol; 2019 Aug 16; 234(10):18317-18328. PubMed ID: 30945294
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
    Wang DY, Gendoo DMA, Ben-David Y, Woodgett JR, Zacksenhaus E.
    Breast Cancer Res; 2019 Jan 31; 21(1):18. PubMed ID: 30704524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
    Cheng S, Huang Y, Lou C, He Y, Zhang Y, Zhang Q.
    Cancer Biol Ther; 2019 Jan 31; 20(3):328-337. PubMed ID: 30336071
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J, Xu HD, Xing XJ, Liang ZT, Xia ZH, Zhao Y.
    Eur Rev Med Pharmacol Sci; 2019 Jun 31; 23(12):5315-5322. PubMed ID: 31298383
    [Abstract] [Full Text] [Related]

  • 19. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R, Pentimalli F, Carlisi D, De Blasio A, Saliba C, Baldacchino S, Degaetano J, Debono J, Caruana-Dingli G, Grech G, Scerri C, Tesoriere G, Giordano A, Vento R, Di Fiore R.
    Oncotarget; 2017 Apr 25; 8(17):28939-28958. PubMed ID: 28423652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.